Search

everythinglearnresearchcommunity

for

Search:↓

Cytokeratin 19 and cytokeratin 15 are key markers for monitoring the quality and self-renewing potential of engineered skin.

TGF-β2 plays a key role in human hair growth and development.

The research developed methods to test drugs that could protect and restore hair follicle protection in a hair loss condition.

Scientists created a detailed map of gene activity in different parts of human hair follicles.

Early diagnosis of frontal fibrosing alopecia is crucial to prevent permanent hair loss.

Scientists found gene mutations that affect hair loss, skin stem cells, and skin disorders, and identified drugs that may help treat blood vessel and skin conditions.

Sca-1+ cells in newborn mouse skin may become fat cells.

Scientists identified a unique type of human skin stem cell that could help with tissue repair.

Small molecules KY19382 and KY19334 may help treat skin cancer by reducing CDK1 levels and blocking harmful cell signals.

Androgens reduce THY1 in skin cells, leading to less fat, more fibrosis, and worse healing in males.

EF and PXE not closely related.

Researchers found that hair follicle stem cells can become squamous cell carcinoma due to Ras activation, which could lead to new treatments.

The research suggests new treatments for skin cancer could target specific cell growth pathways.

Certain cells around hair follicles help improve skin regeneration for potential use in skin grafts.

Laser-pretreated blood for hair loss treatment was more effective and increased stem cells.

Melatonin treatment increases a specific RNA in goat cells that boosts cashmere growth.

Some postmenopausal women with frontal fibrosing alopecia stopped losing hair with finasteride treatment, hinting at a possible hormonal cause.

Keloid scars may form due to changes in skin cell characteristics and specific protein signaling.

The extracellular matrix affects where tumors can start in the body.

Alopecia areata involves complex immune activity, mainly Th1, with potential benefits from broader immune treatments.

A woman with systemic sclerosis developed a unique scarring hair loss combining features of systemic sclerosis and frontal fibrosing alopecia.

A JAK inhibitor improved both severe hair loss and chronic skin disease in one patient.

Tofacitinib successfully treated a woman's severe symptoms from a rare autoimmune condition.

Calancardin B may help reduce inflammation in immune cells.

Mechanotransduction aids healthy wound healing by promoting specific fibroblasts.

Macrophages help hair growth after injury through CX3CR1 and TGF-β1.

A specific RNA can help hair growth in baldness by boosting stem cell activity.

New imaging technology can show up to 40 different markers in hair loss tissue, helping to understand hair disease better.